Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer

Gastroenterology

Volumn 153, Issue 1, 2017, Pages 307-323

  Rex, Douglas K ^a   Boland, C Richard ^b   Dominitz, Jason A ^c   Giardiello, Francis M ^d   Johnson, David A ^e   Kaltenbach, Tonya ^f   Levin, Theodore R ^g   Lieberman, David ^h   Robertson, Douglas J ⁱ  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^f SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g KAISER PERMANENTE MEDICAL CENTER   (United States)

^h OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

ⁱ DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEPTIN; DNA; SEPT9 PROTEIN, HUMAN;

ADENOMA; ADVANCED CANCER; AFRICAN AMERICAN; ARTICLE; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COLORECTAL POLYP; COMORBIDITY; COMPUTED TOMOGRAPHIC COLONOGRAPHY; FAMILY HISTORY; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; FIRST-DEGREE RELATIVE; HUMAN; IMMUNOCHEMISTRY; LIFE EXPECTANCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCREENING TEST; SIGMOIDOSCOPY; UNITED STATES; AGE; BLOOD; CHEMISTRY; COLORECTAL TUMOR; EARLY CANCER DIAGNOSIS; FECES; GENETICS; HEALTH SURVEY; OCCULT BLOOD; PRACTICE GUIDELINE; RISK FACTOR; STANDARDS;

ADENOMA; AGE FACTORS; COLONOGRAPHY, COMPUTED TOMOGRAPHIC; COLONOSCOPY; COLORECTAL NEOPLASMS; DNA; EARLY DETECTION OF CANCER; FECES; HUMANS; OCCULT BLOOD; POPULATION SURVEILLANCE; RISK FACTORS; SEPTINS; SIGMOIDOSCOPY; UNITED STATES;

EID: 85020231443     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2017.05.013     Document Type: Article

References (151)

1. Levin, B., Lieberman, D.A., McFarland, B., et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps. Gastroenterology 134 (2008), 1570–1595.
2. Kahi, C.J., Boland, C.R., Dominitz, J.A., et al. Colonoscopy surveillance after colorectal cancer resection: recommendations of the US multi-society task force on colorectal cancer. Gastrointest Endosc 83 (2016), 489–498.
3. Lieberman, D.A., Rex, D.K., Winawer, S.J., et al. Guidelines for colonoscopy surveillance after screening and polypectomy. Gastroenterology 143 (2012), 844–857.
4. Levin, T.R., Jamieson, L., Burley, D.A., et al. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev 33 (2011), 101–110.
5. Zavoral, M., Suchanek, S., Zavada, F., et al. Colorectal cancer screening in Europe. World J Gastroenterol 15 (2009), 5907–5915.
6. Cenin, D.R., St John, D.J.B., Ledger, M.J.N., et al. Optimizing the expansion of the National Bowel Cancer Screening Program. Med J Aust 201 (2014), 456–461.
7. Jensen, C.D., Corley, D.A., Quinn, V.P., et al. Fecal immunochemical test program over 4 rounds of annual screening: a retrospective study. Ann Intern Med 164 (2016), 456–463.
8. Siegel, R.L., Ward, E.M., Jemal, A., Trends in colorectal cancer incidence rates in the United States by tumor location and stage, 1992-2008. Cancer Epidemiol Biomarkers Prev 21 (2012), 411–416.
9. Klabunde, C.N., Joseph, D.A., King, J.B., et al. Vital signs: colorectal cancer screening test use—United States, 2012. MMWR 62 (2013), 881–888.
10. Sabatino, S.S., White, M.C., Thompson, T.T., et al. Cancer screening test use—United States, 2013. MMWR 64 (2015), 464–468.
11. Siegel, R., Desantis, C., Jemal, A., Colorectal cancer statistics, 2014. CA Cancer J Clin 64 (2014), 104–117.
12. Edwards, B.K., Noone, A.M., Mariotto, A.B., et al. Annual report to the nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer 120 (2014), 1290–1314.
13. Liang, P.S., Wheat, C.L., Abhat, A., et al. Adherence to competing strategies for colorectal cancer screening over 3 years. Am J Gastroenterol 111 (2016), 105–114.
14. US Preventive Services Task Force, Bibbins-Domingo, K., Grossman, D.C., Curry, S.J., et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA 315 (2016), 2564–2575.
15. Inadomi, J.M., Vijan, S., Janz, N.K., et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med 172 (2012), 575–582.
16. Segnan, N., Senore, C., Andreoni, B., et al. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J Natl Cancer Inst 97 (2005), 147–157.
17. Multicentre Australian Colorectal-neoplasia Screening (MACS) Group. A comparison of colorectal neoplasia screening tests: a multicentre community-based study of the impact of consumer choice. Med J Aust 184 (2006), 546–550.
18. Scott, R.G., Edwards, J.T., Fritschi, L., et al. Community-based screening by colonoscopy or computed tomographic colonography in asymptomatic average-risk subjects. Am J Gastroenterol 99 (2004), 1145–1151.
19. Griffith, J.M., Lewis, C.L., Brenner, A.R.T., et al. The effect of offering different numbers of colorectal cancer screening test options in a decision aid: a pilot randomized trial. BMC Med Inform Dec Mak, 8, 2008, 4.
20. Canadian Task Force on Preventive Health Care. Recommendations on screening for colorectal cancer in primary care. CMAJ 188 (2016), 340–348.
21. Rex, D.K., Johnson, D.A., Anderson, J.C., et al. American College of Gastroenterology guidelines for colorectal cancer screening. Am J Gastroenterol 104 (2009), 739–750.
22. ASGE Standards of Practice Committee, Davila, R.E., Rajan, E., Baron, T.H., ASGE guideline: colorectal cancer screening and surveillance. Gastrointest Endosc 63 (2006), 546–557.
23. Senore, C., Ederle, A., Benazzato, L., et al. Offering people a choice for colorectal cancer screening. Gut 62 (2013), 735–740.
24. Symonds, E.L., Pedersen, S., Cole, S.R., et al. Improving participation in colorectal cancer screening: a randomized controlled trial of sequential offers of fecal then blood based non-invasive tests. Asian Pac J Cancer Prev 16 (2015), 8455–8460.
25. Adler, A., Geiger, S., Keil, A., et al. Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in Germany. BMC Gastroenterol, 14, 2014, 183.
26. Rex, D., Colonoscopy: the current king of the hill in the USA. Dig Dis Sci 60 (2015), 639–646.
27. Ma, G.K., Ladabaum, U., Personalizing colorectal cancer screening: a systematic review of models to predict risk of colorectal neoplasia. Clin Gastroenterol Hepatol 12 (2014), 1624–1634.
28. Imperiale, T.F., Monahan, P.O., Stump, T.E., et al. Derivation and validation of a scoring system to stratify risk for advanced colorectal neoplasia in asymptomatic adults: a cross-sectional study. Ann Intern Med 163 (2015), 339–346.
29. Chiu, H.M., Ching, J.Y., Wu, K.C., et al. A risk-scoring system combined with a fecal immunochemical test is effective in screening high-risk subjects for early colonoscopy to detect advanced colorectal neoplasms. Gastroenterology 150 (2016), 617–625.
30. Winawer, S.J., Zauber, A.G., Ho, M.N., Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 329 (1993), 1977–1981.
31. Zauber, A.G., Winawer, S.J., O'Brien, M.J., et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 366 (2012), 687–696.
32. Brenner, H., Hoffmeister, M., Stegmaier, C., et al. Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies. Gut 56 (2007), 1585–1589.
33. Rex, D.K., Ahnen, D.J., Baron, J.A., et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol 107 (2012), 1315–1329.
34. Giardiello, F.M., Allen, J.I., Axilbund, J.E., et al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the U.S. Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc 80 (2014), 197–220.
35. Soetikno, R., Kaltenbach, T., Rouse, R.V., et al. Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA 299 (2008), 1027–1035.
36. Ponugoti, P.L., Cummings, O.W., Rex, D.K., Risk of cancer in small and diminutive colorectal polyps. Dig Liver Dis 49 (2017), 530–534.
37. Lasisi, F., Mouchli, A., Riddell, R., et al. Agreement in interpreting villous elements and dysplasia in adenomas less than one centimeter in size. Dig Liver Dis 45 (2013), 1049–1055.
38. Rex, D.K., Alikhan, M., Cumming, O., et al. Accuracy of pathologic interpretation of colorectal polyps by general pathologists in community practice. Gastrointest Endosc 50 (1999), 468–474.
39. Ponugoti, P., Lin, J., Odze, R., et al. Prevalence of sessile serrated adenoma/polyp in hyperplastic appearing diminutive rectosigmoid polyps. Gastrointest Endosc 85 (2016), 622–627.
40. Abdeljawad, K., Vemulapalli, K.C., Kahi, C.J., et al. Sessile serrated polyp prevalence determined by a colonoscopist with a high lesion detection rate and an experienced pathologist. Gastrointest Endosc 81 (2015), 517–524.
41. Ijspeert, J.E., de Wit, K., van der Vlugt, M., et al. Prevalence, distribution and risk of sessile serrated adenomas/polyps at a center with a high adenoma detection rate and experienced pathologists. Endoscopy 48 (2016), 740–746.
42. Hetzel, J.T., Huang, C.S., Coukos, J.A., et al. Variation in the detection of serrated polyps in an average risk colorectal cancer screening cohort. Am J Gastroenterol 105 (2010), 2656–2664.
43. Kahi, C.J., Hewett, D.G., Norton, D.L., et al. Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol 9 (2011), 42–46.
44. Tinmouth, J., Henry, P., Hsieh, E., et al. Sessile serrated polyps at screening colonoscopy: have they been underdiagnosed?. Am J Gastroenterol 109 (2014), 1698–1704.
45. Payne, S.R., Church, T.R., Wandell, M., et al. Endoscopic detection of proximal serrated lesions and pathologic identification of sessile serrated adenomas/polyps vary on the basis of center. Clin Gastroenterol Hepatol 12 (2014), 1119–1126.
46. Snover, D., Ahnen, D., Burt, R.W., et al. Serrated polyps of the colon and rectum and serrated (“hyperplastic”) polyposis. Bozman, F.T., Carneiro, F., Hruban, R.H., et al. (eds.) WHO classification of tumours. Pathology and genetics. Tumors of the digestive system, 2010, Springer-Verlag, Berlin.
47. Nanda, K.S., Tutticci, N.G., Burgess, N., et al. Caught in the act: endoscopic characterization of sessile serrated adenomas with dysplasia. Gastrointest Endosc 79 (2014), 864–870.
48. Sheridan, T.B., Fenton, H., Lewin, M.R., et al. Sessile serrated adenomas with low and high grade dysplasia and early carcinomas: an immunohistochemical study of serrated lesions “caught in the act.”. Am J Clin Pathol 126 (2006), 564–571.
49. Lash, R.H., Genta, R.M., Sculer, C.M., Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients. J Clin Pathol 63 (2010), 681–686.
50. Bettington, M., Walker, N., Rosty, C., et al. Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma. Gut 66 (2017), 97–106.
51. Kahi, C., Vemulapalli, K.C., Snover, D.C., et al. Findings in the distal colorectum are not associated with proximal advanced serrated lesions. Clin Gastroenterol Hepatol 13 (2015), 345–351.
52. IJspeert, J.E., Tutein Nolthenius, C.J., Kuipers, E.J., et al. CT-colonography vs. colonoscopy for detection of high-risk sessile serrated polyps. Am J Gastroenterol 111 (2016), 516–522.
53. Imperiale, T.F., Ransohoff, D.F., Itzkowitz, S.H., et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med 370 (2014), 1287–1297.
54. Brenner, H., Chang-Claude, J., Seiler, C.M., et al. Long-term risk of colorectal cancer after negative colonoscopy. J Clin Oncol 29 (2011), 3761–3767.
55. Singh, H., Nugent, Z., Demers, A.A., et al. The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterology 139 (2010), 1128–1137.
56. Kahi, C.J., Imperiale, T.F., Juliar, B.E., et al. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol 7 (2009), 770–775.
57. Brenner, H., Chang-Claude, J., Seiler, C.M., et al. Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med 154 (2011), 22–30.
58. Doubeni, C.A., Weinmann, S., Adams, K., et al. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med 158 (2013), 312–320.
59. Brenner, H., Chang-Claude, J., Jansen, L., et al. Reduced risk of colorectal cancer up to 10 years after screening, surveillance or diagnostic colonoscopy. Gastroenterology 146 (2014), 709–717.
60. Mulder, S.A., van Soest, E.M., Dieleman, J.P., et al. Exposure to colorectal examinations before a colorectal cancer diagnosis: a case-control study. Eur J Gastroenterol Hepatol 22 (2010), 437–443.
61. Baxter, N.N., Goldwasser, M.A., Paszat, L.F., et al. Association of colonoscopy and death from colorectal cancer. Ann Inern Med 150 (2009), 1–8.
62. Baxter, N.N., Warren, J.L., Barrett, M.J., et al. Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. J Clin Oncol 30 (2012), 2664–2669.
63. Nishihara, R., Wu, K., Lochhead, P., et al. Long-term colorectal cancer incidence and mortality after lower endoscopy. N Engl J Med 369 (2013), 1095–1105.
64. Doubeni CA, Corley DA, Quinn VP, et al. Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study. Gut. Epub 2016, http://dx.doi.org/10.1136/gutjnl-2016-312712.
65. Mandel, J.S., Church, T.R., Bond, J.H., The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343 (2000), 1603–1607.
66. Schoen, R.E., Pinsky, P.F., Weissfeld, J.L., et al. Colorectal-cancer incidence and mortality with flexible sigmoidoscopy. N Engl J Med 366 (2012), 2345–2357.
67. Kaminski, M.F., Regula, J., Kraszewska, E., et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 362 (2010), 1795–1803.
68. Corley, D.A., Jensen, C.D., Marks, A.R., et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med 370 (2014), 1298–1306.
69. Cooper, G.S., Kou, T.D., Rex, D.K., Complications following colonoscopy with anesthesia assistance: a population-based analysis. JAMA Intern Med 173 (2013), 551–556.
70. Reumkens, A., Ronadagh, E.J., Bakker, et al. Post-colonoscopy complications: A systematic review, time trends, and meta-analysis of population based studies. Am J Gastroenterol 111 (2016), 1092–1101.
71. Bahin, F.F., Rasouli, K.N., Byth, K., et al. Prediction of clinically significant bleeding following wide-field endoscopic resection of large sessile and laterally spreading colorectal lesions: a clinical risk score. Am J Gastroenterol 111 (2016), 1115–1122.
72. Ichise, Y., Horiuchi, A., Nakayama, Y., et al. Prospective randomized comparison of cold snare polypectomy and conventional polypectomy for small colorectal polyps. Digestion 84 (2011), 78–81.
73. Jayanna, M., Burgess, N.G., Singh, R., et al. Cost analysis of endoscopic mucosal resection vs surgery for large laterally spreading colorectal lesions. Clin Gastroenterol Hepatol 14 (2016), 271–278.
74. Law, R., Das, A., Gregory, D., et al. Endoscopic resection is cost-effective compared with laparoscopic resection in the management of complex colon polyps: an economic analysis. Gastrointest Endosc 83 (2016), 1248–1257.
75. Shaukat, A., Rector, T.S., Church, T.R., et al. Longer withdrawal time is associated with a reduced incidence of interval cancer after screening colonoscopy. Gastroenterology 149 (2015), 952–957.
76. Barclay, R.L., Vicari, J.J., Doughty, A.S., et al. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med 355 (2006), 2533–2541.
77. Chen, S.C., Rex, D.K., Endoscopist can be more powerful than age and male gender in predicting adenoma detection at colonoscopy. Am J Gastroenterol 102 (2007), 856–861.
78. Butterly, L., Robinson, C.M., Anderson, J.C., et al. Serrated and adenomatous polyp detection increases with longer withdrawal time: results from the New Hampshire Colonoscopy Registry. Am J Gastroenterol 109 (2014), 417–426.
79. Mysliwiec, P.A., Brown, M.L., Klabunde, C.N., Ransohoff, D.F., Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann Intern Med 141 (2004), 264–271.
80. Pohl, H., Srivastava, A., Bensen, S.P., et al. Incomplete polyp resection during colonoscopy-results of the complete adenoma resection (CARE) study. Gastroenterology 144 (2013), 74–80.e1.
81. Rex, D.K., Rahmani, E.Y., Haseman, J.H., et al. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology 112 (1997), 17–23.
82. Rabeneck, L., Paszat, L.F., Saskin, R., Endoscopist specialty is associated with incident colorectal cancer after a negative colonoscopy. Clin Gastroenterol Hepatol 8 (2010), 275–279.
83. Hassan, C., Rex, D.K., Zullo, A., et al. Loss of efficacy and cost-effectiveness when screening colonoscopy is performed by nongastroenterologists. Cancer 118 (2012), 4404–4411.
84. Ko, C.W., Dominitz, J.A., Green, P., et al. Specialty differences in polyp detection, removal, and biopsy during colonoscopy. Am J Med 123 (2010), 528–535.
85. Lee, J.K., Liles, E.G., Bent, S., et al. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med 160 (2014), 171–181.
86. Robertson, D.J., Lee, J.K., Boland, C.R., et al. Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US Multi-Society Task Force on colorectal cancer Gastrointest Endosc 85 (2016), 2–21.
87. Ladabaum U, Mannalithara A. Comparative effectiveness and cost-effectiveness of a multi-target stool DNA test to screen for colorectal neoplasia. Gastroenterology. 2016;151:427-39.e6.
88. Rosman, A.S., Korsten, M.A., Meta-analysis comparing CT colonography, air contrast barium enema, and colonoscopy meta-analysis comparing CT colonography, air contrast barium enema, and colonoscopy. Am J Med 120 (2007), 203–210.
89. Halligan, S., Wooldrage, K., Dadswell, E., et al. Computed tomographic colonography versus barium enema for diagnosis of colorectal cancer or large polyps in symptomatic patients (SIGGAR): a multicentre randomised trial. Lancet 381 (2013), 1185–1193.
90. Johnson, C.D., Herman, B.A., Chen, M.H., et al. The National CT Colonography Trial: assessment of accuracy in participants 65 years of age and older. Radiology 263 (2012), 401–408.
91. Stoop, E.M., de Haan, M.C., de Wijkerslooth, T.R., et al. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomized controlled trial. Lancet Oncol 13 (2012), 55–64.
92. Sakamoto, T., Mitsuzaki, K., Utsunomiya, D., et al. Detection of flat colorectal polyps at screening CT colonography in comparison with conventional polypoid lesions. Acta Radiol 53 (2012), 714–719.
93. IJspeert, J.E., Tutein Nolthenius, C.J., Kuipers, E.J., et al. CT-colonography vs. colonoscopy for detection of high-risk sessile serrated polyps. Am J Gastroenterol 111 (2016), 516–522.
94. Zalis, M.E., Barish, M.A., Choi, J.R., et al. CT colonography reporting and data system: a consensus proposal. Radiology 236 (2005), 3–9.
95. Benson, M., Pier, J., Kraft, S., et al. Optical colonoscopy and virtual colonoscopy numbers after initiation of a CT colonography program: long term data. J Gastrointestin Liver Dis 21 (2012), 391–395.
96. Schwartz, D.C., Dasher, K.J., Said, A., et al. Impact of a CT colonography screening program on endoscopic colonoscopy in clinical practice. Am J Gastroenterol 103 (2008), 346–351.
97. Atkin, W.S., Edwards, R., Kralj-Hans, I., et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicenter randomized controlled trial. Lancet 375 (2010), 1624–1633.
98. Segnan, N., Armaroli, P., Bonelli, L., et al. Once-only sigmoidoscopy in colorectal cancer screening follow-up findings of the Italian Randomized Controlled trial-SCORE. JNCI 103 (2011), 1310–1322.
99. Hoff, G., Grotmol, T., Skovlund, E., et al. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomized controlled trial. BMJ, 338, 2009, b1846.
100. Zubarik, R., Ganguly, E., Benway, D., et al. Procedure-related abdominal discomfort in patients undergoing colorectal cancer screening: a comparison of colonoscopy and flexible sigmoidoscopy. Am J Gastroenterol 97 (2002), 3056–3061.
101. Rex, D.K., Adler, S.N., Aisenberg, J., et al. Accuracy of capsule colonoscopy in detecting colorectal polyps in a screening population. Gastroenterology 148 (2015), 948–957.e2.
102. Church, T.R., Wandell, M., Lofton-Day, C., et al. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Gut 63 (2014), 317–325.
103. Adler, A., Geiger, S., Keil, A., et al. Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in Germany. BMC Gastroenterology, 14, 2014, 183.
104. Parikh, R.B., Prasad, V., Blood-based screening for colon cancer: a disruptive innovation or simply a disruption?. JAMA 315 (2016), 2519–2520.
105. Ladabaum, U., Alvarez-Osorio, L., Rösch, T., et al. Cost-effectiveness of colorectal cancer screening in Germany: current endoscopic and fecal testing strategies versus plasma methylated Septin 9 DNA. Endosc Int Open 2 (2014), e96–e104.
106. Patel, S.S., Kilgore, M.L., Cost effectiveness of colorectal cancer screening strategies. Cancer Control 22 (2015), 248–258.
107. Landsdorp-Vogelaar, I., Knudsen, A.B., Brenner, H., Cost-effectiveness of colorectal cancer screening. Epidemiol Rev 33 (2011), 88–100.
108. Hanly, P., Skally, M., Fenlon, H., et al. Cost-effectiveness of computed tomography colonography in colorectal cancer screening: a systematic review. Int J Technol Assess Health Care 28 (2012), 415–423.
109. Greuter, M.J., Berkhof, J., Fireman, R.J., et al. The potential of imaging techniques as a screening tool for colorectal cancer: a cost-effectiveness analysis. Br J Radiol, 89, 2016, 20150910.
110. Wong, M.C., Ching, J.Y., Chan, V.C., et al. The comparative cost-effectiveness of colorectal cancer screening using fecal immunochemical test vs colonoscopy. Scientific Reports, 2015 http://dx.doi.org/10.1038/srep13568.
111. Skally, M., Hanly, P., Sharp, L., et al. Cost-effectiveness of fecal DNA screening for colorectal cancer: a systematic review and quality appraisal of the literature. Appl Econ Health Policy 11 (2013), 181–192.
112. Knudsen, A.B., Landsdorp-Vogelaar, I., Rutter, L.M., et al. Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population. J Natl Cancer Inst 102 (2010), 1238–1252.
113. Hassan, C., Zullo, A., Winn, S., Cost-effectiveness of capsule endoscopy in screening for colorectal cancer. Endoscopy 40 (2008), 414–421.
114. Dinh, T., Ladabaum, U., Alperin, P., et al. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer. Clin Gastroenterol Hepatol 11 (2013), 1158–1166.
115. Jenkins, M., Colorectal cancer screening is cost-effective in the elderly who have had less intense prior screening, high baseline risk of colorectal cancer and less comorbidities. Evid Based Med, 21, 2016, 182.
116. van Hees, F., Habbema, J.D., Meester, R.G., et al. Should colorectal cancer screening be considered in elderly persons without previous screening?. A cost-effectiveness analysis Ann Intern Med 160 (2014), 750–759.
117. Levin, T.R., Farraye, F.A., Schoen, R.E., et al. Quality in the technical performance of screening flexible sigmoidoscopy: recommendations of an international multi-society task group. Gut 54 (2005), 807–813.
118. Rex, D.K., Bond, J.H., Winawer, S., et al. Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the US Multi-Society Task Force in Colorectal Cancer. Am J Gastroenterol 97 (2002), 1296–1308.
119. Rex, D.K., Petrini, J.L., Baron, T.H., et al. Quality indicators for colonoscopy. Gastrointest Endosc 63:4 Suppl (2006), S16–S28.
120. Rex, D.K., Schoenfeld, P.S., Cohen, J., et al. Quality indicators for colonoscopy. Am J Gastroenterol 110 (2015), 72–90 http://dx.doi.org/10.1038/ajg.2014.385.
121. Knudsen, A.B., Zauber, A.G., Rutter, C.M., et al. Estimation of benefits, burden, and harms of colorectal cancer screening strategies; modeling study for the US Preventive Services Task Force. JAMA 315 (2016), 2595–2609.
122. Lindor, N.M., Familial colorectal cancer type X: the other half of hereditary nonpolyposis colon cancer syndrome. Surg Oncol Clin N Am, 2009, 637–645.
123. Samadder, N.J., Smith, K.R., Hanson, H., Increased risk of colorectal cancer among family members of all ages, regardless of age of index case at diagnosis. Clin Gastroenterol Hepatol 13 (2015), 2305–2311.
124. Samadder, N.J., Curtin, K., Tuohy, T.M.F., et al. Increased risk of colorectal neoplasia among family members of patients with colorectal cancer: a population-based study in Utah. Gastroenterology 147 (2014), 814–821.
125. Lowery, J.T., Ahnen, D.J., Schroy, P.C., et al. Understanding the contribution of family history to colorectal cancer risk and its clinical implications: a state-of-the-science review. Cancer 122 (2016), 2633–2645.
126. Quintero, E., Carrillo, M., Gimeno-Garcia, A.Z., et al. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening. Gastroenterology 147 (2014), 1021–1030.
127. Schoen, R.E., Razzak, A., Yu, K.J., et al. Incidence and mortality of colorectal cancer in individuals with a family history of colorectal cancer. Gastroenterology 149 (2015), 1438–1445.
128. Fuchs, C.S., Giovannucci, E.L., Colditz, G.A., et al. A prospective study of family history and the risk of colorectal cancer. N Engl J Med 331 (1994), 1669–1674.
129. Cottet, V., Pariente, A., Nalet, B., et al. Colonoscopic screening of the first-degree relatives of patients with large adenomas; increased risk of colorectal tumors. Gastroenterology 133 (2007), 1086–1092.
130. Wong, M.C., Ching, J.Y., Chiu, H.M., et al. Risk of colorectal neoplasia in individuals with self-reported family history: a prospective colonoscopy study from 16 Asia-Pacific regions. Am J Gastroenterol 111 (2016), 1621–1629.
131. Ng, S.C., Lau, J.Y.W., Chan, F.K.L., et al. Risk of advanced adenomas in siblings of individuals with advanced adenomas: a cross-sectional study. Gastroenterology 150 (2016), 608–616.
132. Ahnen, D.J., Wade, S.W., Jones, W.F., et al. The increasing incidence of young-onset colorectal cancer: a call to action. Mayo Clin Proc 89 (2014), 216–224.
133. Printz, C., Colorectal cancer incidence increasing in young adults. Cancer 121 (2015), 1912–1913.
134. Rex, D.K., Mark, D., Clarke, B., et al. Flexible sigmoidoscopy plus air-contrast barium enema versus colonoscopy for evaluation of symptomatic patients without evidence of bleeding. Gastrointest Endosc 42 (1995), 132–138.
135. Lieberman, D.A., De Garmo, P.L., Fleischer, D.E., Colonic neoplasia in patients with nonspecific GI symptoms. Gastrointest Endosc 51 (2000), 647–651.
136. Imperiale, T.F., Wagner, D.R., Lin, C.Y., et al. Results of screening colonoscopy among persons 40 to 49 years of age. N Engl J Med 346 (2002), 1781–1785.
137. Bardou, M., Barkun, A.N., Martel, M., Obesity and colorectal cancer. Gut 62 (2013), 933–947.
138. Hann, L.M., Jacobs, E.J., Thun, M.J., The association between cigarette smoking and risk of colorectal cancer in a large prospective cohort from the United States. Cancer Epidemiol Biomarkers Prev 18 (2009), 3362–3367.
139. Guraya, S.Y., Association of type 2 diabetes mellitus and the risk of colorectal cancer: A meta-analysis and systematic review. World J Gastroenterol 21 (2015), 6026–6031.
140. Williams, R., White, P., Nieto, J., et al. Colorectal cancer in African Americans: an update. Clin Transl Gastroenterol, 7, 2016, e185.
141. QuickStats: Colorectal cancer screening among adults aged 50-75 years, by race/ethnicity – National Health interview Study, United States, 2000-2015. MMWR Morb Mortal Wkly Rep, 65, 2016, 1042.
142. Carethers, J.M., Screening for colorectal cancer in African-Americans: determinants and rationale for an earlier age to commence screening. Dig Dis Sci 60 (2015), 711–721.
143. Ashktorab, H., Vimenay, K., Brim, H., et al. Colorectal cancer in young African Americans: is it time to revisit guidelines and prevention?. Dig Dis Sci 61 (2016), 3026–3030.
144. Lin, J., Qiu, M., Xu, R., et al. Comparison of survival and clinicopathologic features in colorectal cancer among African American, Caucasian, and Chinese patients treated in the United States: Results from the surveillance epidemiology and end results (SEER) database. Oncotarget 6 (2015), 33935–33943.
145. Agrawal, S., Bhupinderjit, A., Bhutani, M.S., et al. Colorectal cancer in African Americans. Am J Gastroenterol 100 (2005), 515–523.
146. Qaseem, A., Denberg, T.D., Hopkins RH Screening for colorectal cancer; a guidance statement from the American College of Physicians. Ann Intern Med 156 (2012), 378–386.
147. Paquette, I.M., Ying, J., Shah, S.A., et al. African Americans should be screened at an earlier age for colorectal cancer. Gastrointest Endosc 82 (2015), 878–883.
148. Landsdorp-Vogelaar, I., van Ballegooijen, M., Zauber, A.G., et al. Individualizing colonoscopy screening by sex and race. Gsatrointest Endosc 70 (2009), 96–108.
149. Lieberman, D.A., Williams, J.L., Holub, J.L., et al. Race, ethnicity, and sex affect risk for polyps > 9 mm in average-risk individuals. Gastroenterology 147 (2014), 351–358.
150. Thompson, V.L., Lander, S., Xu, S., et al. Identifying key variables in African American adherence to colorectal cancer screening: the application of data mining. BMC Public Health, 14, 2014, 1173 http://dx.doi.org/10.1186/1471-2458-14-1173.
151. Horne, H.N., Phelan-Emrick, D.F., Pollack, C.E., et al. Effect of patient navigation on colorectal cancer screening in a community-based randomized controlled trial of urban African American adults. Cancer Causes Control 26 (2015), 239–246.